Our CEO Roman Grunt was very proud to be a guest speaker at the First International Forum on Innovation and Research of Drugs for Cancer event, and share how QUINTA-ANALYTICA manages it’s clinical trials. We were excited and pleased to accompany so many internationally renowned experts from academia and industry, including the fantastic other guest speakers to discuss the latest progress in cancer research. Thank you Atengen, Inc. for inviting us to join you in Tianjin, China!

Additional News

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency